Study on differentially expressed gene of the liver of treble fatty metabolism genes mutant mice using cDNA microarray

Chinese Journal of Medical Genetics

Volumn 22, Issue 1, 2005, Pages 27-30

  Jin, Xiao Lei ^a   Sun, Wen Xia ^a   Shi, Yu Ping ^b   Li, Jia Hui ^a   Chen, Han Min ^a   Pan, Jie ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; CDNA microarray; Differentially expressed gene; Liver tissue; Treble genes mutation

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FATTY ACID; GENE PRODUCT; PANCREATIC LIPASE RELATED PROTEIN 1; SQUALENE SYNTHASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGING; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOSKELETON; DISEASE MODEL; DNA MICROARRAY; DOWN REGULATION; FATTY ACID METABOLISM; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC RISK; HYPERLIPIDEMIA; LIVER; METABOLIC DISORDER; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; FEMALE; GENE EXPRESSION PROFILING; HYPERLIPIDEMIAS; LIPASE; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LDL; RECEPTORS, LEPTIN; TRIGLYCERIDES;

ANIMALIA;

EID: 13544265501     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Knowles JW, Maeda N. Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol, 2000, 20: 2336-2345.
2. Hasty AH, Shimano H, Osuga JI, et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem, 2001, 276: 37402-37408.
3. Horvat S, Bünger L. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay for the mouse leptin receptor (Leprdb) mutation. Lab Anim, 1999, 33: 380-384.
4. Amano S, Yamagishi SI, Kato N, et al. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem Biophys Res Commun, 2002, 299: 183-188.
5. Han EK, Gehrke L, Tahir SK, et al. Modulation of drug resistance by a-tubulin in paclitaxel-resistant human lung cancer cell lines. Euro J Cancer, 2000, 36: 1565-1571.
6. Yumiko NT, Yamashita S, Miyagawa J, et al. Localization of CD36 and scavenger receptor class A in human coronary arteries-a possible difference in the contribution of both receptors to plaque formation. Atheroscler, 2001, 156: 297-305.
7. Bjorbaek C, Buchholz RM, Davis SM, et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem, 2001, 276: 4747-4755.
8. Lord RSA, Bobryshev YV. Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms. Cardiov Surg, 2002, 10: 405-414.